NA Radioimmunoassay Market - Industry Trends and Forecast to 2030
North America radioimmunoassay market is projected to register a substantial CAGR of 4.4% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentations
Middle East and Africa Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of North America radioimmunoassay market are:
• Increase in the demand for error-free and accurate results of high throughput and automated procedures
• Rise in the technological advancements
• Strategic initiatives by market players
• Increasing significance of research and development in medical science
Market Players
The key market players in North America radioimmunoassay market are listed below:
• PerkinElmer Inc.
• MP BIOMEDICALS
• Tecan Trading AG
• Merck KGaA
• Immuno-Biological Laboratories Co,Ltd.
• EUROIMMUN Medizinische Labordiagnostika AG
• KAMIYA BIOMEDICAL COMPANY
• Beckman Coulter, Inc.
• MyBioSource.com.
• Berthold Technologies GmbH & Co.KG
• Hidex Oy.
• Abcam plc
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook